Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients

NCT04757857 is registered in ClinicalTrials.gov with Hospital Alemão Oswaldo Cruz as lead sponsor.

NCT NCT04757857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04757857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients
Lead sponsor
Hospital Alemão Oswaldo Cruz
Phase
Phase 4
Overall status
Terminated
Start date
September 29, 2020
Completion date
August 30, 2022
Enrollment
660 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19